|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets: | |||||
| Cash and cash equivalents | |||||
| Cash and securities segregated under federal and other regulations | |||||
| Accounts receivable, net | |||||
| Restricted cash | |||||
| Clearing house performance bonds and guarantee funds | |||||
| Participant margin deposits | |||||
| Receivables from broker-dealers, futures commission merchants, and clearing organizations | |||||
| Current portion of derivative assets | |||||
| Other current assets | |||||
| Assets held for sale | |||||
| Total current assets | |||||
| Investments | |||||
| Fixed assets and internally developed software, net | |||||
| Fixed assets | |||||
| Internally developed software | |||||
| Total fixed assets and internally developed software, net | |||||
| Internally developed software, net | |||||
| Goodwill | |||||
| Other intangible assets, net | |||||
| Deferred tax asset, net | |||||
| Derivative assets, net of current portion | |||||
| Other assets, net | |||||
| Total assets | |||||
| Liabilities and Stockholders’ Equity | |||||
| Current liabilities: | |||||
| Accounts payable and other liabilities | |||||
| Accrued compensation payable | |||||
| Current portion of long-term debt | |||||
| Deferred transaction revenues | |||||
| Clearing house performance bonds and guarantee funds | |||||
| Participant margin deposits | |||||
| Payables to customers | |||||
| Payables to clearing organizations | |||||
| Liabilities held for sale | |||||
| Total current liabilities | |||||
| Long-term debt | |||||
| Deferred income taxes | |||||
| Puttable common stock, net of current portion | |||||
| Puttable warrants issued with debt | |||||
| Other non-current liabilities | |||||
| Total liabilities | |||||
| Commitments and contingencies (Note 15) | |||||
| Stockholders’ equity: | |||||
| Convertible preferred stock - par value $0.001 (25,000,000 authorized, and 0 issued and outstanding at December 31, 2025 and 781,859 issued and outstanding at December 31, 2024) | |||||
| Common stock - voting and nonvoting, par value $0.001 (600,000,000 authorized (400,000,000 voting, 200,000,000 nonvoting); XX issued and outstanding common stock at June 30, 2026 (XX voting, 0 nonvoting), 85,890,086 issued and 85,536,287 outstanding common stock at December 31, 2025 (85,536,287 voting, 0 nonvoting) | |||||
| Common stock in treasury, at cost, 353,799 shares at September 30, 2025 and 38,469 shares at December 31, 2024 | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Accumulated other comprehensive loss, net | |||||
| Total stockholders’ equity | |||||
| Total liabilities and stockholders’ equity |
Loading...